Know Cancer

or
forgot password

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas


Phase 1
18 Years
N/A
Not Enrolling
Both
Neoplasm, Lymphomas, Neoplasm Metastasis

Thank you

Trial Information

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas

Inclusion Criteria


None - Study has been terminated.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

PTX-5001

NCT ID:

NCT00023166

Start Date:

May 2001

Completion Date:

May 2002

Related Keywords:

  • Neoplasm
  • Lymphomas
  • Neoplasm Metastasis
  • Phase I
  • Open label
  • Safety/efficacy
  • Lymphomas
  • Advanced primary and/or metastatic solid tumors
  • Neoplasms
  • Neoplasm metastasis
  • Neoplasms
  • Lymphoma
  • Neoplasm Metastasis

Name

Location